OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 08:00PM GMT
Adi Jayanthi - JPMorgan - Analyst

Hi, everyone. Good afternoon. Thank you all for joining us today for our conversation with OPKO Health. My name is Adi Jayanthi from the JPMorgan's Healthcare Investment Banking team. I'm really excited today to introduce the management team at OPKO Health.

So with us today, we have Dr. Phil Frost, CEO and Chairman of OPKO; Steve Rubin, Executive Vice President, Administration; Adam Logal, Senior Vice President and CFO; Jon Cohen, Senior Vice President of OPKO and Executive Chairman of BioReference Laboratories; and Katherine Stueland, President and CEO of GeneDx. So welcome to all of you and thank you very much for joining us here at the conference.

Maybe before we get going, obviously, you guys are a diversified business and would love to just get an overview of the company and any particular areas that you'd like to highlight.

Jon R. Cohen - OPKO Health, Inc. - Senior VP & Director, Executive Chairman of BioReference Laboratories

Sure. So I'll give you a little brief overview for the BioReference piece

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot